Kotliarova et al. using different glioma cell lines have shown that GSK-3β activation promotes cell survival [30], whereas Ma et al. [40] have shown that GSK-3β activation is required for the induction of apoptosis in SK-N-MC neuroblastoma cells. This evidence concerns the gene GSK3B and central nervous system cancer.